Research article · 2016
Conference abstractPublished 10 Aug 2015
Formulation and evaluation of Galantamine loaded PLGA nanoparticles for Alzheimer’s disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
PLGA nanoparticles have a novel controlled targeted drug delivery which offer several potential benefits. PLGA nanoparticles had shown an excellent capacity for the association of GH, an anti-alzheimeric drug. It possesses the requisite properties necessary for formulation of PLGA nanoparticles drug delivery system, like rapid onset of action. PLGA is a versatile polymer with good biodegradability and biocompatibility properties. In the present study PLGA nanoparticles containing GH were prepared by modified nanoprecipitation method. The increase in the proportion of the polymer caused an increase in particle size of the nanoparticles. An increase in drug content and entrapment efficiency were also observed. From the SEM analysis of nanodispersion indicated that the particles are discrete, smooth and spherical. The release studies indicated that the release of GH from formulation F2 is consistent and the maximum of 92.56% of drug is released at the end of 24th hour. The dosing frequency can be reduced to once a day when compared to conventional form. The in vitro cell line studies indicates that Galantamine loaded PLGA nanoparticles exhibited increased in IC 50 concentration when compared with pure Galantamine. The percentage cell viability of nanoformulation was increased considerably. This indicates increase penetration of Galantamine in the brain cells.Thus it can be concluded GPNF2 can serve as a potential drug delivery to the treatment for Alzheimer’s disease. However detailed preclinical and pharmacokinetic studies are required to confirm the activity.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Targeted delivery of Rivastigmine loaded PLGA nanoparticles into the brain for treating Alzheimer?s disease
Conference abstract
Formulation, optimization and evaluation of Atorvastatin calcium-fenofibrate loaded PLGA nanoparticles
Research article · 2015
Formulation development, systematic optimization of PLGA-CS-Tween 80 nanoparticles of Rivastigmine Tartrate for treatment of Alzheimer’s disease
Research article · 3 May 2019
Formulation and optimization of Mucoadhesive Galantamine Loaded Nanoparticles
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Guturi Kishor Babu”

